Physician profile
Haley E Douglas
NPI 1093305583
$581.52
in general payments reported to CMS, 2019-2025
16 companies · $46.14 in 2025
The $46.14 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.35 · 2022: $445 · 2023: $13.14 · 2025: $46.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $173.74 | 2021-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $71.05 | 2022 | |
| Medtronic, INC. | $49.22 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.98 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.76 | 2022 | |
| Insulet Corporation | $31.95 | 2022 | |
| Boston Scientific Corporation | $27.28 | 2025 | Spaceoar Vue System - 10ml |
| Caris Mpi, INC. | $18.86 | 2025 | Mi Cancer Seek |
| Corcept Therapeutics | $18.76 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $18.26 | 2022 | |
| Pfizer INC. | $17.00 | 2022 | |
| Abbvie INC. | $16.87 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.28 | 2022 | |
| Amgen INC. | $15.59 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.68 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.